First-ever Creutzfeldt-Jakob disease treatment shows encouraging results
Early study results have highlighted the promising performance of the world’s first treatment for Creutzfeldt-Jakob disease, potentially a landmark step toward treating the deadly...
Life-extending injection for multiple myeloma available on the NHS
The NHS has announced that a life-extending injection for multiple myeloma, a bone marrow cancer, will be available to 350 patients per year in...
Improving the effectiveness of the tuberculosis vaccine
Researchers have found a new way to enhance the tuberculosis vaccine by adding an antibody that can improve long-term effectiveness.
Tuberculosis is a bacterial infection...
Molnupiravir recommended by WHO to reduce COVID-19 hospitalisations
The World Health Organization (WHO) has expressed that the molnupiravir antiviral medication should be administered to patients with non-severe COVID-19 who are at an...
UK Aid funding for the development of a Zika virus vaccine
Scientists in Nottingham have been awarded £462,462 for the development of a Zika virus vaccine from UK Aid funding for research into vaccines for...
Insomnia treatment for women with night sweats found to be safe
A study indicates that suvorexant, an insomnia treatment, could provide a novel therapeutic option for peri- and postmenopausal women.
Hot flashes and night sweats are...
Saphnelo approved in the EU for treatment for systemic lupus erythematosus
Saphnelo is a first-in-class type I interferon receptor antibody for patients with moderate to serve systemic lupus erythematosus.
Saphnelo (anifrolumab), licensed by AstraZeneca, has been...
Inhaled vaccine for COVID-19 protects against variants of concern
In a groundbreaking development toward curbing the transmission of SARS-CoV-2, scientists have developed an innovative inhaled vaccine for COVID-19 that offers robust disease protection.
Pioneered...
New life-extending drug for advanced womb cancer on the NHS
A 30-minute treatment, the first of its kind for advanced womb cancer, is being rolled out for women across England.
Womb cancer affects the womb...
Cyproterone acetate drug may increase benign brain tumour risk
A UK study has signified that high doses of a commonly used hormonal treatment – cyproterone acetate – may elevate the risk of benign...
NHS to roll out new gene therapy for metachromatic leukodystrophy
The NHS has agreed on a deal for life-saving treatment for metachromatic leukodystrophy that will offer babies and young children the prospect of a...
Should hormone replacement therapy be available without a prescription?
The MHRA has launched a public consultation on whether hormone replacement therapy (HRT) should be available from pharmacies.
Hormone replacement therapy is a treatment to...
Atezolizumab now available on the NHS for lung cancer patients
Thousands of lung cancer patients in England will be fast-tracked the revolutionary new drug, atezolizumab, which significantly reduces the risk of cancer returning.
The Medicines...
Zika vaccine demonstrates effectiveness at preventing the virus
A groundbreaking Zika vaccine has been proven to prevent the Zika virus effectively in preclinical animal studies.
The novel Zika vaccine was developed at the...
New blood cancer gene defect can be treated with existing drugs
A blood cancer gene defect could be treated with drugs already available for cancers with similar defective genes, scientists at Queen’s University Belfast and...
Changing the lives of children with a new cystic fibrosis treatment
The National Health Service (NHS) has announced a new cystic fibrosis treatment is now available, which will benefit hundreds of children.
Patients in England were...
Angina medicine could be used as a kidney disease treatment
An existing angina medicine could be used as a kidney disease treatment, according to new research from the University of Edinburgh.
Researchers have found that...
New treatment reduces effects of peanut allergy to benefit children
Thousands of children and young people will receive pioneering treatment for peanut allergy after NHS England secured the first deal of its kind in...
Phenylketonuria (PKU) drug now available to patients in England
The NHS has agreed to a deal to secure a drug for Phenylketonuria (PKU), a rare, deliberating disorder for patients of all ages for...
Drug may effectively help patients with COVID pneumonia
A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may benefit some...
